Abstract
Neuropeptides are widely distributed in the central nervous system where they serve as neuroregulators. Recent interest has focused on their role in degenerative neurologic diseases. In this review is described the anatomy of neuropeptides in cerebral cortex and basal ganglia as a framework for interpreting neuropeptide alterations in Alzheimer’s disease (AD) and Huntington’s disease (HD).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tomlinson, B.E., Irving, D. and Blessed, G. (1981). Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J. Neurol. Sci. 49, 419–428.
Donoghue J.P., Wenthold, R.J., and Altschuler, R.A. (1985). Localization of glutaminase-like and aspartate aminotransferase-like immunoreactivity in neurons of cerebral cortex. J. Neurosci. 5, 2597–2608.
Fonnum, F. (1984). Glutamate: A neurotransmitter in mammalian brain. J. Neurochem. 42, 1–11.
Chronwall, B.M., Chase, T.N. and O’Donohue, T.L. (1984). Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci. Lett. 52, 213–217.
Kowall, N.W., Beal, M.F. and Martin, J.B. (1986). Somatostatin, neuropeptide Y, NADPH diaphorase neurons do not contain neurofibrillary tangles in Alzheimer’s disease cortex. Ann. Neurol. 20, 124.
Nakamura, S. and Vincent, S.R. (1985). Acetylcholinesterase and somatostatin-immuno-reactivity coexist in human neocortex. Neurosci. Lett. 61, 183–187.
Somogyi, P., Hodgson, A.J., Smith, A.D., et al. (1984). Differential populations of GABAergic neurons in the visual cortex and hippocampus of the cat contain somatostatin or cholecystokinin immunoreactive material. J. Neurosci. 4, 2590–2603.
Vincent, S.R., Johansson, O., Hokfelt, T. et al. (1982). Neuropeptide coexistence in human cortical neurons. Nature 298, 65–67.
Emson, P.C. and Hunt, S.P. (1981). Anatomical chemistry of the cerebral cortex. In The Organization of the Cerebral Cortex, Schmitt, F.O., Worden, F.G., Adelman, G., Dennis, S.G., eds., MIT Press, Cambridge, MA, pp. 325–345.
Hendry, S.H., Jones, E.G. and Beinfeld, M.C. (1983). CCK immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc. Natl. Acad. Sci. USA 80, 2400–2404.
Hendry, S.H., Jones, E.G., DeFelipe, J., et al. (1984). Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. USA 81, 6526–6530.
Hendry, S.H., Jones, E.G. and Emson, P.C. (1984). Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J. Neurosci. 4, 2497–2517.
Jones, E.G. and Hendry, S.H. (1986). The peptide containing neurons of the primate cerebral cortex. In Implications of Neuropeptides in Neurological and Psychiatric Diseases, Martin, J.B., Barchus, J., eds., Raven, New York, pp. 163–178.
Schmechel, D.E., Vickrey, B.G., Fitzpatric, D. and Elde, R.P. (1984). GABAergic neurons of mammalian cerebral cortex: Widespread subclass defined by somatostatin content. Neurosci. Lett. 47, 227–232.
Jones, E.G. and Hendry, S.H. (1985). GABAergic, substance P-immunoreactive neurons in monkey cerebral cortex. Neurosci. Abst. 11, 145.
Eckenstein, F. and Baughman, R. (1984). Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide. Nature 309, 153–155.
Hendry, S.H., Houser, C.R., Jones, E.G. and Vaughn, J.E. (1983). Synaptic organization of immunocytochemically identified GABA neurons in the monkey sensory-motor cortex. J. Neurocytol. 12, 639–660.
Hendry, S.H. and Jones, E.G. (1981). Sizes and distributions of intrinsic neurons incorporating tritiated GABA in monkey sensory-motor cortex. J. Neurosci. 1, 390–408.
Houser, C.R., Hendry, S.H., Jones, E.G. and Vaughn, J.E. (1983). Morphological diversity of immunocytochemically identified GABA neurons in monkey sensory-motor cortex. J. Neurocytol. 12, 617–638.
Candy, J.M., Perry, R.H., Perry, E.K., et al. (1983). Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s disease. J. Neurol. Sci. 54, 277–289.
Coyle, J.T., Price, D.L. and DeLong, M.R. (1983). Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science 219, 1184–1190.
Rossor, M.N., Garrett, N.J. and Johnson, A.I. (1982). A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 105, 313–330.
Perry, E.K., Tomlinson, B.E., Blessed, G., et al. (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. (Clin. Res.) 2, 1457–1459.
Bondareff, W., Mountjoy, C.Q. and Roth, M. (1981). Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1, 783–784.
Crow, T.J., Cross, A.J., Cooper, S.J., et al. (1984). Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23, 1561–1569.
Curcio, C.A. and Kemper, T. (1984). Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density. J. Neuropath. Exp. Neurol. 143, 359–368.
Hardy, J., Adolfsson, R., Alafuzoff, L, et al. (1985). Transmitter deficits in Alzheimer’s disease. Neurochem. Int. 7, 545–563.
Mann, D.M., Lincoln, J., Yates, P.O., et al. (1980). Changes in the monoamine containing neurons of the human central nervous system in senile dementia. Br. J. Psychiatry 136, 533–541.
Mann, D.M., Yates, P.O. and Marcyniuk, B. (1985). Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer’s disease. Neurosci. Lett. 56, 51–55.
Mountjoy, C.Q., Roth, M., Evans, N.J. and Evans, H.M. (1983). Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4, 1–11.
Terry, R.D., Peck, A., DeTeresa, R., et al. (1981). Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184–192.
Davies, P., Katzman, R. and Terry, R.D. (1980). Reduced somatostatin-like immuno-reactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288, 279–280.
Graveland, G.A., Williams, R.S. and Difiglia M. (1985). Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington’s disease. Science 277, 770–773.
Ferrier, I.N., Cross, A.J., Johnson, J.A., et al. (1983). Neuropeptides in Alzheimer type dementia. J. Neurol. Sci. 62, 159–170.
Rossor, M.N., Emson, P.C., Mountjoy, C.Q., et al. (1980). Reduced amounts of immuno-reactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci. Lett. 20, 373–377.
Rossor, M.N., Iversen, L.L., Reynolds, G.P., et al. (1984). Neurochemical characteristics of early and late onset types of Alzheimer’s disease. Br. Med. J. (Clin. Res.) 288, 961–964.
Beal, M.F., Mazurek, M.F., Svendsen, C.N., et al. (1986). Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer’s disease. Ann. Neurol. 20, 489–495.
Beal, M.F., Growdon, J.H., Mazurek, M.F. and Martin, J.B. (1986). CSF somatostatin-like immunoreactivity in dementia. Neurology 36, 294–297.
Beal, M.F., Mazurek, M.F., Black, P.B. and Martin, J.B. (1985). CSF somatostatin in neurological diseases. J. Neurol. Sci. 71, 91–104.
Candy, J.M., Gascoigne, A.D., Biggins, J. A., et al. (1985). Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer’s disease. J. Neurol. Sci. 71, 315–323.
Beal, M.F., Mazurek, M.F., Chattha, G.K., et al. (1986). Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer’s disease. Ann. Neurol. 20, 282–288.
Beal, M.F., Mazurek, M.F., Tran, V.T., et al. (1985). Somatostatin receptors are reduced in cerebral cortex in Alzheimer’s disease. Science 229, 289–291.
Crystal, H.A. and Davies P. (1982). Cortical substance P-like immunoreactivity in cases of Alzheimer’s disease and senile dementia of the Alzheimer type. J. Neurochem. 38, 1781–1784.
Yates, CM., Harmar, A.J., Rosie, R., et al. (1983). Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immunoreactivity in post-mortem from cases of Alzheimer-type dementia and Down’s syndrome. Brain Res. 258, 45–52.
Beal, M.F. and Mazurek, M.F. Substance P-like immunoreactivity is reduced in Alzheimer’s disease cerebral cortex. Neurology, in press.
Vincent, S.R., Satoh, K., Armstrong, D.M. and Fibiger, H.C. (1983). Substance P in the ascending cholinergic reticular system. Nature 306, 688–691.
Sakamoto, N., Takatsuji, K., Shiosaka, S. and Tohyama, M. (1985). Evidence for the existence of substance P-like immunoreactive neurons in the human cerebral cortex: An immunohistochemical analysis. Brain Res. 325, 322–324.
Bissette, G., Reynolds, G.P., Kilts, CD., et al. (1985). Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. JAMA 265, 3067–3069.
Desouza, E.B., Whitehouse, P.J., Kuhar, M.J., et al. (1986). Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer’s disease. Nature 319, 593–595.
Rossor, M.N., Fahrenkrug, J., Emson, P.C., et al. (1980). Reduced cortical choline acetyl-transferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Res. 201, 249–253.
Rossor, M.N., Rehfeld, J.F., Emson, P.C., et al. (1981). Normal cortical concentrations of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity insenile dementia of Alzheimer type. Life Sci. 29, 405–410.
Hays, S.E. and Paul, S.M. (1982). CCK receptors and human neurological disease. Life Sci. 31, 319–322.
Nemeroff, C.B., Bissette, G., Busby, W.H., et al. (1983). Regional brain concentrations of neurotensin, thyrotropin releasing hormone and somatostatin in Alzheimer’s disease. Neurosci. Abst. 9, 1052.
Rossor, M.N., Emson, P.C. and Mountjoy, C.A. (1982). Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer’s type. Exp. Brain Res. 5 (Suppl), 33–157.
Yates, CM., Fink, G., Bennie, J.G., et al. (1985). Neurotensin immunoreactivity in postmortem brain is increased in Down’s syndrome but not in Alzheimer-type dementia. J. Neurol. Sci. 67, 327–335.
Dewied, D. (1976). Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments. Life Sci. 19, 685–690.
Mazurek, M.F., Beal, M.F. and Martin, J.B. (1985). Vasopressin in postmortem Alzheimer brain. Ann. Neurol. 18, 143–144.
Mazurek, M.F., Beal, M.F., Bird, E.D. and Martin, J.B. Oxytocin concentration is increased in the hippocampus in Alzheimer’s disease. Neurology, in press.
Iversen, L.L. and Bloom, F.E. (1979). Studies of the uptake of 3H-GABA and 3H-glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography. Brain Res. 41, 131–143.
Ellison, D.W., Beal, M.F., Mazurek, M.F., Malloy, J.R., Bird, E.D. and Martin J.B. Amino acid neurotransmitter abnormalities in Huntington’s disease and the quinolinic acid animal model of Huntington’s disease. Brain, in press.
Alzheimer, A. (1907). Uber ein eigenartige erkrankung der hinnrinde. Allg. Z. Psychiatr. 64, 146–148.
Probst, A., Basler, V., Brow, B. and Ulrich J. (1983). Neuritic plaques in senile dementia of Alzheimer type: A golgi analysis in the hippocampal region. Brain Res. 268, 249–254.
Joynt, R.J. and McNeill, T.H. (1984). Neuropeptides in aging and dementia. Peptides (Fayetteville) 5 (Suppl. 1), 269–274.
Roberts, G.W., Crow, T.J. and Rolak, J.M. (1985). Location of neuronal tangles in somatostatin neurons in Alzheimer’s disease. Nature 314, 92–94.
Morrison, J.H., Rogers, J., Scherr, S., et al. (1985). Somatostatin immunoreactivity in neuritic plaques of Alzheimer’s patients. Nature 31, 490–492.
Nakamura, S. and Vincent, S.R. (1986). Somatostatin and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer’s type. Brain Res. 370, 11–20.
Chan-Palay, V., Lang, W., Allen, Y.S., et al. (1985). Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer’s-type dementia. J. Comp. Neurol. 238, 390–400.
Chan-Palay, V., Lang, W., Haesler, U., Kohler, C. and Yasargil G. (1986). Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer’s-type dementia. J. Comp. Neurol. 248, 376–394.
Armstrong, D.M., Leroy, S., Shields, D., and Terry, R.D. (1985). Somatostatin-like immunoreactivity within neuritic plauqes. Brain Res. 338, 71–79.
Struble, R.G., Kitt, CA., Walker, L.C., Cork, L.C and Price D.L. (1984). Somatostatiner-gic neurities in senile plaques of aged non-human primates. Brain Res. 324, 394–396.
Kowall, N.W., Beal, M.F. and Martin, J.B. (1986). Neuropeptide Y, somatostatin and NADPH diaphorase reactive fibers contribute to senile plaque formation in Alzheimer’s disease. Neurology 36 (Suppl 1), 224.
Armstrong, D.M. and Terry, R.D. (1985). Substance P immunoreactivity within neuritic plaques. Neurosci. Lett. 58, 139–144.
Price, D.L., Powers, R.E., Walker, L.C, Struble, R.G., Whitehouse, P.J., Vale, W.W. and DeSouza, E.B. (1986). Corticotropin releasing factor immunoreactivity in senile plaques. Neurosci. Abst. 12, 98.
Struble, R.G., Powers, R.E., Casanova, M.F., et al. (1985). Multiple transmitter-specific markers in senile plaques in Alzheimer’s disease. Neurosci. Abst. 11, 953.
Graveland, G. A., Williams, R.S. and Difiglia, M. (1985). A golgi study of the human striatum: Neurons and afferent fibers. J. Comp. Neurol. 234, 317–333.
Graybiel, A.M. and Ragsdale C.W. (1983). Biochemical anatomy of the striatum. In Chemical Neuroanatomy, Emson, P.C., ed., Raven, New York, pp. 427–504.
Ribak, CE., Vaughn, J.E. and Roberts, E. (1979). The GABA neurons and their axon terminals in the rat corpus striatum as demonstrated by GAD immunocytochemistry. J. Comp. Neurol. 187, 261–284.
Aronin, N., Difiglia, M., Graveland, G.A., et al. (1984). Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum. Brain Res. 300, 376–380.
Difiglia, M., Aronin, N. and Martin, J.B. (1982). Light and electron microscopic localizations of immunoreactive leu-enkephalin in the monkey basal ganglia. J. Neurosci. 2, 203–320.
Bolam, J.P., Somogyi, P., Takagi, H., et al. (1983). Localization of substance P-like im-munoreactivity in neurons and nerve terminals in the neostriatum of the rat: A correlated light and electron microscopic study. J. Neurocytol. 12, 325–344.
Chesselet, M.F. and Graybiel, A.M. (1983). Met-enkephalin-like and dynorphin-like im-munoreactivities of the basal ganglia of the cat. Life Sci. 33, 37–40.
Zamir, N., Palcovitz, M., Weber, E., et al. (1984). A dynorphinergic pathway of leu-enkephalin production in rat substantia nigra. Nature 307, 643–645.
Bolam, J.P., Clarke, D.J., Smith, A.D. and Somogyi, P. (1986). A type of aspiny neuron in the rat neostriatum accumulates [3H]gamma-aminobutyric acid: Peptides derived from pro-dynorphin are decreased in basal ganglia of Huntington’s disease brains. Brain Res. 372, 155–158.
Difiglia, M. and Aronin, N. (1984). Quantitative electron microscopic study of immunoreactive somatostatin axons in the rat neostriatum. Neurosci. Lett. 50, 325–331.
Kowall, N., Ferrante, R.J., Beal, M.F. and Martin, J.B. (1985). Characteristics, distribution and interrelationships of somatostatin, neuropeptide Y, and NADPH-diaphorase in human caudate nucleus. Neurosci. Abst. 11, 209.
Takagi, H., Somogyi, P., Somogyi, J. and Smith, A.D. (1983). Fine structural studies of a type of somatostatin immunoreactive neuron and its synaptic connections in the rat striatum: A correlated light and electron microscopic study. J. Comp. Neurol. 214, 1–16.
Vincent, S.R. and Johansson, O. (1983). Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity. A light and electron microscopic study. J. Comp. Neurol. 217, 264–270.
Vincent, S.R., Johansson, O., Hokfelt, T., et al. (1983). NADPH-diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J. Comp. Neurol. 217, 252–263.
Takagi, H., Mizuta, H., Matsuda, T., et al. (1984). The occurrence of cholecystokinin-like immunoreactive neurons in the rat neostriatum: Light and electron microscopic analysis. Brain Res. 309, 346–369.
Theriault, E., Marshall, P.E. and Landis, D.M. (1984). Morphology of neurons containing VIP-like immunoreactivity in the rat striatum. Neurosci. Abst. 10, 701.
Vincent, S.R., Staines, W.A. and Fibiger, H.C. (1983). Histochemical demonstration of separate populations of somatostatin and cholinergic neurons in the rat striatum. Neurosci. Lett. 35, 111–114.
Zaborszky, L., Alheid, G.F., Beinfield, M.C., et al. (1985). Cholecystokinin innervation of the ventral striatum: A morphological and radioimmunological study. Neuroscience 14, 427–453.
Aronin, N., Cooper, P.E., Lorenz, L.J., et al. (1983). Somatostatin is increased in the basal ganglia in Huntington’s disease. Ann. Neurol. 13, 519–526.
Buck, S.H., Burks, T.F., Brown, M. and Yamamura, H.I. (1981). Reduction in basal ganglia and substantia nigra substance P levels in Huntington’s disease. Brain Res. 209, 464–469.
Emson, P.C., Arregui, A., Clement-Jones, V., et al. (1980). Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington’s disease. Brain Res. 199, 147–160.
Gale, J.S., Bird, E.D., Spokes, E.G., et al. (1978). Human substance P: Distribution in controls and Huntington’s chorea. J. Neurochem. 30, 633–634.
Kanazawa, I., Bird, E., O’Connell, R. and Powell, D. (1977). Evidence for a decrease in substance P content of substantia nigra in Huntington’s chorea. Brain Res. 120, 387–392.
Kanazawa, I., Sasaki, H., Muramoto, O., et al. (1985). Studies on neurotransmitter markers and striatal neuronal cell density in Huntington’s disease and dentatorubropallidoluysian atrophy. J. Neurol. Sci. 70, 151–165.
Marshall, P.E., Landis, D.M. and Zalneraitis, E. (1983). Immunocytochemical studies of substance P and leucine-enkephalin in Huntington’s disease. Brain Res. 298, 11–26.
Dawbarn, D., Zamin, N., Waters, CM., Hunt, S.P., Emson, P.C. and Brownstein, M.J. (1983). Combination of golgi-staining, autoradigoraphy and electronmicroscopy. J. Comp. Neurol. 213, 121–134.
Seizinger, B.R., Leibisch, D.C., Kish, S.J., Arendt, R.M., Hornykiewicz, O. and Herz, A. (1986). Opioid peptides in Huntington’s disease: Alterations in prodynorphin and proenke-phalin system. Brain Res. 378, 405–408.
Nemeroff, C.B., Youngblood, W.W., Manberg, P.J., et al. (1983). Regional brain concentrations of neuropeptides in Huntington’s chorea and schizophrenia. Science 221, 972–975.
Dawbarn, D., Dequidt, M.E. and Emson, P.C. (1985). Survival of basal ganglia neuropeptide Y/somatostatin neurons in Huntington’s disease. Brain Res. 340, 251–260.
Beal, M.F., Ellison, D.W., Mazurek, M.F., Malloy, J.R., Bird, E.D. and Martin, J.B. (1986). Neuropeptide Y is increased in Huntington’s disease. Ann Neurol.
Beal, M.F., Domesick, V.B. and Martin, J.B. (1985). Effects of lesions in the amygdala and periventricular hypothalamus on striatal somatostatin-like immunoreactivity. Brain Res. 330, 309–316.
Beal, M.F. and Martin, J.B. (1983). Effect of lesions on somatostatin-like immunoreactivity in the rat striatum. Brain Res. 266, 67–73.
Ferrante, R.J., Kowall, N.W., Beal, M.F., et al. (1985). Selective sparing of a class of striai neurons in Huntington’s disease. Science 230, 561–563.
Ferrante, R.J., Beal, M.F., Kowall, N.W., Richardson, E.P. and Martin, J.B. (1987). Sparing of acetylcholinesterase-containing striatal neurons in Huntington’s disease. Brain Res. 411, 162–166.
Schwarcz, R., Foster, A.C., French, E.D., et al. (1984). Excitotoxic models for neurodegenerative disorders. Life Sci. 35, 19–32.
Beal, M.F., Kowall, N.W., Ellison, D.W., et al. (1986). Replication of the neurochemical characteristics of Huntington’s disease with quinolinic acid. Nature 321, 168–171.
Schwarcz, R., Whetsell, W.O. and Mangano, R.M. (1983). Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316–318.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Martin, J.B., Beal, M.F. (1988). Neuropeptide Abnormalities in Alzheimer’s and Huntington’s Diseases. In: Ferrendelli, J.A., Collins, R.C., Johnson, E.M. (eds) Neurobiology of Amino Acids, Peptides and Trophic Factors. Topics in the Neurosciences, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1721-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1721-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8969-2
Online ISBN: 978-1-4613-1721-0
eBook Packages: Springer Book Archive